Metabolic characterization of Withania somnifera from different regions of India using NMR spectroscopy.
暂无分享,去创建一个
Y. Choi | R. Verpoorte | M. P. López-Gresa | K. Mahadik | A. Namdeo | Ajay Sharma | K. Yadav | H. Kim | R. Gawande
[1] R. Roy,et al. Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extracts. , 2010, Phytochemistry.
[2] Saifullah,et al. Metabolic classification of South American Ilex species by NMR-based metabolomics. , 2010, Phytochemistry.
[3] Y. Choi,et al. NMR-based metabolomic analysis of plants , 2010, Nature Protocols.
[4] S. Kulkarni,et al. Withania somnifera: An Indian ginseng , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[5] R. Tuli,et al. Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection. , 2008, Phytochemical analysis : PCA.
[6] R. Tuli,et al. Phytochemical and genetic analysis in selected chemotypes of Withania somnifera. , 2006, Phytochemistry.
[7] A. Bown,et al. Gamma-aminobutyrate: defense against invertebrate pests? , 2006, Trends in plant science.
[8] Robert Verpoorte,et al. Metabolomic differentiation of Cannabis sativa cultivars using 1H NMR spectroscopy and principal component analysis. , 2004, Journal of natural products.
[9] I. Khan,et al. Quantitative HPLC analysis of withanolides in Withania somnifera. , 2003, Fitoterapia.
[10] H. Matsuda,et al. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. , 2001, Bioorganic & medicinal chemistry.
[11] A. Saxena,et al. Adaptogenic activity of a novel, withanolide‐free aqueous fraction from the roots of Withania somnifera Dun. , 2001, Phytotherapy research : PTR.
[12] S. Dagenais,et al. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. , 2000, Alternative medicine review : a journal of clinical therapeutic.
[13] V. Dorneanu,et al. New data referring to chemistry of Withania somnifera species. , 1990, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.
[14] D. Lavie,et al. 5,20α(R)-dihydroxy-6α,7α-epoxy-1-oxo-(5α) witha-2,24-dienolide, a new steroidal lactone from withania coagulans , 1971 .
[15] D. Lavie,et al. A chemotaxonomic study of Withania somnifera (L.) dun. , 1968 .
[16] D. Lavie,et al. Constituents of Withania somnifera Dun. III. The Side Chain of Withaferin A*,1 , 1965 .
[17] Y. Choi,et al. Analysis of metabolic variation and galanthamine content in Narcissus bulbs by 1H NMR. , 2010, Phytochemical analysis : PCA.
[18] Y. Choi,et al. Application of Two-Dimensional Nuclear Magnetic Resonance Spectroscopy to Quality Control of Ginseng Commercial Products , 2006, Planta medica.
[19] Robert Verpoorte,et al. Metabolic fingerprinting of Ephedra species using 1H-NMR spectroscopy and principal component analysis. , 2005, Chemical & pharmaceutical bulletin.
[20] R. Sharma,et al. Phytochemical variability in commer- cial herbal products and preparations of Withania somnifera (Ashwagandha) , 2004 .
[21] R. Mathur,et al. NEUROPROTECTION BY WITHANIA SOMNIFERA ROOT EXTRACT AGAINST LITHIUM-PILOCARPINE-INDUCED SEIZURES , 1998 .
[22] F. Frolow,et al. Chlorinated withanolides from Withania somnifera and Acnistus breviflorus , 1981 .